Toranomon Hospital; Medical Oncology
Tokyo, Japan
General hospital in Minato, Tokyo
2 Chome-2-2 Toranomon, Minato City, Tokyo 105-0001
About Toranomon Hospital; Medical Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Clinical Trials at Toranomon Hospital; Medical Oncology
During the past decade, Toranomon Hospital; Medical Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
2012-09-03
2016-04-30
Terminated
415
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
2017-09-20
2030-03-06
Active, not recruiting
382
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Toranomon Hospital; Medical Oncology"
#1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Toranomon Hospital; Medical Oncology
According to Clinical.Site data, the most researched conditions in "Toranomon Hospital; Medical Oncology" are
"Bladder Cancer" (1 trials), "Cancer" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Gastric Cancer" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Toranomon Hospital; Medical Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Toranomon Hospital; Medical Oncology
Most popular intervention types in "Toranomon Hospital; Medical Oncology" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "Obinutuzumab" (2 trials), "Prednisone" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Toranomon Hospital; Medical Oncology
The vast majority of trials in "Toranomon Hospital; Medical Oncology" are
5 trials for "All" genders.
Clinical Trials Status at Toranomon Hospital; Medical Oncology
Currently, there are NaN active trials in "Toranomon Hospital; Medical Oncology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Toranomon Hospital; Medical Oncology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Toranomon Hospital; Medical Oncology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".